{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:31:31Z","timestamp":1782217891251,"version":"3.54.5"},"reference-count":49,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To test the validity of an augmented tuberculosis skin test (a\u2010<jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content>) combined with Quantiferon <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content>\u2010gold<jats:sup>\u00ae<\/jats:sup> (<jats:styled-content style=\"fixed-case\">QFTG<\/jats:styled-content>) test for the screening of latent tuberculosis infection (<jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content>) in patients with rheumatoid arthritis (<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>) being considered for treatment with biologic disease\u2010modifying anti\u2010rheumatic drugs or targeted synthetic disease\u2010modifying anti\u2010rheumatic drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Standard <jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content> using 1 tuberculin unit (<jats:styled-content style=\"fixed-case\">TU<\/jats:styled-content>) of purified protein derivative (<jats:styled-content style=\"fixed-case\">PPD<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> RT<\/jats:styled-content>23 strain) was carried out. If the positivity was less as compared to the general population, then a\u2010<jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content> using 10 <jats:styled-content style=\"fixed-case\">TU PPD<\/jats:styled-content> was employed. Simultaneously, <jats:styled-content style=\"fixed-case\">QFTG<\/jats:styled-content> test was also performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Using standard <jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content>, 6\/44 (13.6%), patients were positive compared to the reported figures of ~ 40% of the general population; 38 of the remaining <jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content>\u2010negative patients were then given an a\u2010<jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content> with 10 <jats:styled-content style=\"fixed-case\">TU PPD<\/jats:styled-content>; eight of them dropped out. Of the remaining 30 patients, eight (26.6%) were positive. Another 70 patients tested directly with a\u2010<jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content>; 22 (31.4%) were found positive. Thus, of a total of 100 patients tested with a\u2010<jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content>, 30 (30%) were positive. In 54 a\u2010<jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content> negative patients, <jats:styled-content style=\"fixed-case\">QFTG<\/jats:styled-content> was done; seven (13%) were positive. Thus, in combined a\u2010<jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content> with <jats:styled-content style=\"fixed-case\">QFTG<\/jats:styled-content>, 43% of the <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients were found positive, suggestive of the presence of <jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Combined a\u2010<jats:styled-content style=\"fixed-case\">TST<\/jats:styled-content> with <jats:styled-content style=\"fixed-case\">QFTG<\/jats:styled-content> testing gave 43% positivity among <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients, which is close to the reported ~ 40% Mantoux positivity in the general population. Therefore, this method for the screening of <jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content> in Indian patients with <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> being considered for tumor necrosis factor alpha treatment could be satisfactory for offsetting <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> flare. It may apply to other high\u2010burden <jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> countries around the world.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1756-185x.13261","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T03:42:51Z","timestamp":1516246971000},"page":"1563-1571","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Screening for latent tuberculosis infection among patients with rheumatoid arthritis in the era of biologics and targeted synthetic disease\u2010modifying anti\u2010rheumatic drugs in India, a high\u2010burden <scp>TB<\/scp> country: The importance of Mantoux and Quantiferon\u2010<scp>TB<\/scp> Gold tests"],"prefix":"10.1111","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-9506","authenticated-orcid":false,"given":"Anand N.","family":"Malaviya","sequence":"first","affiliation":[{"name":"Department of Rheumatology ISIC Superspeciality Hospital New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal K.","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Rheumatology ISIC Superspeciality Hospital New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Rawat","sequence":"additional","affiliation":[{"name":"Department of Rheumatology ISIC Superspeciality Hospital New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Baghel","sequence":"additional","affiliation":[{"name":"Department of Rheumatology ISIC Superspeciality Hospital New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravita","family":"Thakran","sequence":"additional","affiliation":[{"name":"Department of Rheumatology ISIC Superspeciality Hospital New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qamar","family":"Zaheer","sequence":"additional","affiliation":[{"name":"Department of Rheumatology ISIC Superspeciality Hospital New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriram","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Rheumatology ISIC Superspeciality Hospital New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Department of Rheumatology ISIC Superspeciality Hospital New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10524"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10529"},{"key":"e_1_2_8_4_1","first-page":"1473","article-title":"Immune status and risk for infection in patients receiving chronic immunosuppressive therapy","volume":"32","author":"Gl\u00fcck T","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq242"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283025ec2"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-8077.2006.00188.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39480"},{"key":"e_1_2_8_10_1","unstructured":"WHO.Guidelines on the management of LTBI. Available from URL:http:\/\/www.who.int\/tb\/challenges\/ltbi\/en\/(Last accessed 14 April 2017)."},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01910-2015"},{"key":"e_1_2_8_12_1","unstructured":"World Health Organization.Guidelines for the management of latent tuberculosis infection. WHO\/HTM\/TB\/2015.01. Geneva WHO 2014. Last accessed 15 May 17."},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01245-2015"},{"key":"e_1_2_8_14_1","unstructured":"CDC. Available from URL:https:\/\/www.cdc.gov\/tb\/publications\/ltbi\/diagnosis.htm(Last accessed 15 May 2017)"},{"key":"e_1_2_8_15_1","unstructured":"CDC.Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000; 49 (No. RR\u20106). Available from URL:www.cdc.gov\/MMWR\/PDF\/rr\/rr4906.pdfLast accessed 15 May 2017"},{"key":"e_1_2_8_16_1","unstructured":"Tuberculosis (TB). Available from URL:http:\/\/www.who.int\/tb\/challenges\/ltbi\/en\/; (Last accessed 15 May 2017)"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0865"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0982-1"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1027-z"},{"key":"e_1_2_8_20_1","first-page":"70","article-title":"Some immunological parameters in rheumatoid arthritis from India","volume":"27","author":"Palit J","year":"1977","journal-title":"Biomedicine\/(publi\u00e9e pour l'A I C I G)"},{"key":"e_1_2_8_21_1","article-title":"Steroids decrease prevalence of positive tuberculin skin test in rheumatoid arthritis: implications on anti\u2010TNF therapies","volume":"430134","author":"Agarwal S","year":"2014","journal-title":"Interdisciplin Perspect Infect Dis Article ID"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02728860"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.5005\/jp\/books\/10992_11"},{"key":"e_1_2_8_24_1","first-page":"404","article-title":"Standardization of Mantoux test","author":"NEW 23","year":"2002","journal-title":"Indian Pediatr 39"},{"key":"e_1_2_8_25_1","first-page":"639","article-title":"Prevalence of nonspecific sensitivity to tuberculin in a South Indian rural population","volume":"64","author":"Chakraborty AK","year":"1976","journal-title":"Indian J Med Res"},{"key":"e_1_2_8_26_1","first-page":"121","article-title":"Prevalence Of Tuberculosis In A South Indian District \u2010Twelve Years After Initial Survey","volume":"26","author":"Gothi GD","year":"1979","journal-title":"Ind J Tuberculosis"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi141"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.22.2746"},{"key":"e_1_2_8_29_1","unstructured":"Available from URL:http:\/\/www.tbfacts.org\/tb-statistics-india\/(accessed 15 May 2017)."},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"e_1_2_8_31_1","first-page":"473","article-title":"Tuberculosis in a rural population of South India: a five\u2010year epidemiological study","volume":"51","author":"National Tuberculosis Institute, Bangalore","year":"1974","journal-title":"Bull World Health Org"},{"key":"e_1_2_8_32_1","first-page":"172","article-title":"PPD RT23 for tuberculin surveys in India","volume":"7","author":"Chadha VK","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.5005\/jp\/books\/10992_12"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"e0172881","DOI":"10.1371\/journal.pone.0172881","article-title":"Symptom screening rules to identify active pulmonary tuberculosis: findings from the Zambian South African Tuberculosis and HIV\/AIDS Reduction (ZAMSTAR) trial prevalence surveys","volume":"12","author":"Claessens MM","year":"2017","journal-title":"PLoS ONE"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11137"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22768"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69063-6"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-8077.2006.00181.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081042"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090854"},{"key":"e_1_2_8_42_1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0973-3698(09)60005-4","article-title":"Success of an earlier recommended screening strategy for preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumour necrosis factor\u2010\u03b1 inhibitors in India\u2014a follow\u2010up report","volume":"4","author":"Malaviya A","year":"2009","journal-title":"Ind J Rheumatol"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-1522"},{"key":"e_1_2_8_44_1","first-page":"1437","article-title":"Can BCG vaccinated children be included for tuberculin surveys to estimate annual risk of tuberculous infection in India?","volume":"8","author":"Chadha VK","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_8_45_1","first-page":"1192","article-title":"False\u2010positive tuberculin skin tests: what is the absolute effect of BCG and nontuberculous mycobacteria?","volume":"10","author":"Farhat M","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_8_46_1","first-page":"149","article-title":"Tuberculin testing in a partly vaccinated population","volume":"39","author":"National Tuberculosis Institute, Bangalore","year":"1992","journal-title":"Indian J Tuberc"},{"key":"e_1_2_8_47_1","first-page":"137","article-title":"Waning of BCG scar","volume":"40","author":"Chanabasavaiah R","year":"1993","journal-title":"Indian J Tuberc"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051854"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02829815"},{"key":"e_1_2_8_50_1","first-page":"139","article-title":"Tuberculin sensitivity in BCG vaccinated children and its implications for apparent rate of infection (ARI) estimation","volume":"47","author":"Chadha VK","year":"2000","journal-title":"Indian J Tuberc"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.13261","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13261","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1756-185X.13261","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T20:58:38Z","timestamp":1694293118000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.13261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1111\/1756-185X.13261"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.13261","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"2018-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}